Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2019 | The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label | Wang Y.-H.; Chen C.-B.; Tassaneeyakul W.; Saito Y.; Aihara M.; Choon S.E.; Lee H.Y.; Chang M.M.; Roa F.D.; Wu C.-W.; Zhang J.; Nakkam N.; Konyoung P.; Okamoto-Uchida Y.; Cheung C.M.-T.; Huang J.-W.; Ji C.; Cheng B.; Hui R.C.-Y.; CHIA-YU CHU ; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Huang Y.-H.; Lu C.-W.; Yang C.-Y.; Lin Y.-T.; Chi M.-H.; Ho H.-C.; Lin J.-Y.; Yang C.-H.; Chang Y.-C.; Su S.-C.; Wang C.W.; Fan W.-L.; Hung S.-I.; Chung W.-H.; for the Asian Severe Cutaneous Adverse Reaction Consortium | Clinical Pharmacology and Therapeutics | 50 | 47 | |
2017 | Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians | Chen C.-B.; Hsiao Y.-H.; Wu T.; Hsih M.-S.; Tassaneeyakul W.; Jorns T.P.; Sukasem C.; Hsu C.-N.; Su S.-C.; Chang W.-C.; Hui R.C.-Y.; CHIA-YU CHU ; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Sun P.-L.; Lee H.-E.; Yang C.-Y.; Kao P.-H.; Yang C.-H.; Ho H.-C.; Lin J.-Y.; Chang Y.-C.; Chen M.-J.; Lu C.-W.; Ng C.Y.; Kuo K.-L.; Lin C.-Y.; Yang C.-S.; Chen D.-P.; Chang P.-Y.; Wu T.-L.; Lin Y.-J.; Weng Y.-C.; Kuo T.-T.; Hung S.-I.; Chung W.-H.; For the Taiwan Severe Cutaneous Adverse Reaction Consortium | Neurology | 104 | 90 | |
2018 | Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study | HSIEN-YI CHIU ; Hui R.C.-Y.; Huang Y.-H.; Huang R.-Y.; Chen K.-L.; Tsai Y.-C.; Lai P.-J.; Wang T.-S.; TSEN-FANG TSAI | Acta Dermato-Venereologica | 56 | 45 |